Kenward H. Vong
RIKEN Baton Zone Program 2-1 Hirosawa Wako Shi Saitama 351-0198 Japan
Zone, 3510198, Japan
Zone, 3510198, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Membrane Fusion-Mediated Cytosolic Delivery of Threose Nucleic Acids via Homotypic Nanoparticles Overcomes Drug Resistance in Triple-Negative Breast Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 13, 2026
Development of palladium-based multivalent lectin-directed artificial metalloenzymes.
Journal: Bioorganic & medicinal chemistry
Published: January 18, 2026
Chagasin-based carriers designed for the cancer-targeted release of proteases.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: December 31, 2025
Gold-Catalyzed Carbonyl Release and its Adaptation for Prodrug Therapy Using Multivalent Lectin-Directed Artificial Metalloenzymes.
Journal: JACS Au
Published: October 07, 2025
Synthetic prodrug design enables biocatalytic activation in mice to elicit tumor growth suppression.
Synthetic prodrug design enables biocatalytic activation in mice to elicit tumor growth suppression.
Journal: Nature communications
Published: August 06, 2021
Bioorthogonal release of anticancer drugs via gold-triggered 2-alkynylbenzamide cyclization.
Journal: Chemical science
Published: June 07, 2021
Prodrug Activation by Gold Artificial Metalloenzyme-Catalyzed Synthesis of Phenanthridinium Derivatives via Hydroamination.
Journal: Angewandte Chemie (International ed. in English)
Published: January 09, 2021
Disrupting tumor onset and growth via selective cell tagging (SeCT) therapy.
Journal: Science advances
Published: January 04, 2021
Unlocking the therapeutic potential of artificial metalloenzymes.
Journal: Proceedings of the Japan Academy. Series B, Physical and biological sciences
Published: March 13, 2020
Last Updated: 09/26/2026